Direct Oral Anticoagulants in Patients Undergoing Urgent Reperfusion for Nonvalvular Atrial Fibrillation-Related Ischemic Stroke: A Brief Report on Literature Evidence.
Luca MasottiElisa GrifoniAlessandro DeiVieri VannucchiFederico MoroniGrazia PanigadaCostanza NicotraStefano SpolveriGiancarlo LandiniPublished in: Neurology research international (2019)
Small sample size real life studies seem to demonstrate that the introduction of DOACs in the early phase of NVAF-related AIS undergoing urgent reperfusion is efficacious and safe. Prospective RCTs are necessary to confirm these findings.
Keyphrases
- direct oral anticoagulants
- atrial fibrillation
- venous thromboembolism
- patients undergoing
- oral anticoagulants
- acute myocardial infarction
- left atrial
- catheter ablation
- left atrial appendage
- cerebral ischemia
- systematic review
- heart failure
- acute ischemic stroke
- coronary artery disease
- blood brain barrier
- brain injury
- mitral valve